nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—IARS—embryo—colon cancer	0.079	0.153	CbGeAlD
Mupirocin—IARS—epithelium—colon cancer	0.0645	0.125	CbGeAlD
Mupirocin—IARS—smooth muscle tissue—colon cancer	0.0621	0.12	CbGeAlD
Mupirocin—IARS—renal system—colon cancer	0.0598	0.116	CbGeAlD
Mupirocin—IARS—lymphoid tissue—colon cancer	0.0496	0.096	CbGeAlD
Mupirocin—IARS—digestive system—colon cancer	0.049	0.0948	CbGeAlD
Mupirocin—Application site burn—Fluorouracil—colon cancer	0.0475	0.0984	CcSEcCtD
Mupirocin—IARS—bone marrow—colon cancer	0.0452	0.0874	CbGeAlD
Mupirocin—IARS—vagina—colon cancer	0.0433	0.0838	CbGeAlD
Mupirocin—IARS—liver—colon cancer	0.0365	0.0707	CbGeAlD
Mupirocin—IARS—lymph node—colon cancer	0.028	0.0542	CbGeAlD
Mupirocin—Application site pain—Fluorouracil—colon cancer	0.0226	0.0469	CcSEcCtD
Mupirocin—Blepharitis—Fluorouracil—colon cancer	0.0162	0.0335	CcSEcCtD
Mupirocin—Stinging—Fluorouracil—colon cancer	0.0123	0.0255	CcSEcCtD
Mupirocin—Furunculosis—Methotrexate—colon cancer	0.0122	0.0252	CcSEcCtD
Mupirocin—Tenderness—Fluorouracil—colon cancer	0.0114	0.0236	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Methotrexate—colon cancer	0.0112	0.0232	CcSEcCtD
Mupirocin—Cellulitis—Fluorouracil—colon cancer	0.011	0.0227	CcSEcCtD
Mupirocin—Furuncle—Methotrexate—colon cancer	0.0106	0.0219	CcSEcCtD
Mupirocin—Dermatitis contact—Fluorouracil—colon cancer	0.00984	0.0204	CcSEcCtD
Mupirocin—Mouth ulceration—Vincristine—colon cancer	0.00966	0.02	CcSEcCtD
Mupirocin—Swelling—Fluorouracil—colon cancer	0.0082	0.017	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Irinotecan—colon cancer	0.008	0.0166	CcSEcCtD
Mupirocin—Cellulitis—Capecitabine—colon cancer	0.00765	0.0158	CcSEcCtD
Mupirocin—Dry skin—Fluorouracil—colon cancer	0.00663	0.0137	CcSEcCtD
Mupirocin—Mouth ulceration—Capecitabine—colon cancer	0.00629	0.013	CcSEcCtD
Mupirocin—Ear pain—Capecitabine—colon cancer	0.00592	0.0123	CcSEcCtD
Mupirocin—Swelling—Capecitabine—colon cancer	0.00573	0.0119	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Capecitabine—colon cancer	0.00535	0.0111	CcSEcCtD
Mupirocin—Epistaxis—Fluorouracil—colon cancer	0.00526	0.0109	CcSEcCtD
Mupirocin—Haemoglobin—Irinotecan—colon cancer	0.00525	0.0109	CcSEcCtD
Mupirocin—Rhinitis—Irinotecan—colon cancer	0.00524	0.0108	CcSEcCtD
Mupirocin—Haemorrhage—Irinotecan—colon cancer	0.00522	0.0108	CcSEcCtD
Mupirocin—Haemoglobin—Fluorouracil—colon cancer	0.00503	0.0104	CcSEcCtD
Mupirocin—Rhinitis—Fluorouracil—colon cancer	0.00501	0.0104	CcSEcCtD
Mupirocin—Haemorrhage—Fluorouracil—colon cancer	0.005	0.0104	CcSEcCtD
Mupirocin—Pharyngitis—Fluorouracil—colon cancer	0.00496	0.0103	CcSEcCtD
Mupirocin—Immune system disorder—Irinotecan—colon cancer	0.00472	0.00977	CcSEcCtD
Mupirocin—Mouth ulceration—Methotrexate—colon cancer	0.00468	0.0097	CcSEcCtD
Mupirocin—Dry skin—Capecitabine—colon cancer	0.00463	0.00959	CcSEcCtD
Mupirocin—Erythema—Fluorouracil—colon cancer	0.00435	0.00902	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Methotrexate—colon cancer	0.00399	0.00825	CcSEcCtD
Mupirocin—Cough—Irinotecan—colon cancer	0.00397	0.00821	CcSEcCtD
Mupirocin—Anaphylactic shock—Vincristine—colon cancer	0.00381	0.00789	CcSEcCtD
Mupirocin—Anaphylactic shock—Irinotecan—colon cancer	0.00371	0.00768	CcSEcCtD
Mupirocin—Epistaxis—Capecitabine—colon cancer	0.00367	0.0076	CcSEcCtD
Mupirocin—Anaphylactic shock—Fluorouracil—colon cancer	0.00355	0.00736	CcSEcCtD
Mupirocin—Haemoglobin—Capecitabine—colon cancer	0.00351	0.00727	CcSEcCtD
Mupirocin—Rhinitis—Capecitabine—colon cancer	0.0035	0.00726	CcSEcCtD
Mupirocin—Haemorrhage—Capecitabine—colon cancer	0.0035	0.00724	CcSEcCtD
Mupirocin—Pharyngitis—Capecitabine—colon cancer	0.00347	0.00718	CcSEcCtD
Mupirocin—Pain—Vincristine—colon cancer	0.00326	0.00675	CcSEcCtD
Mupirocin—Pain—Irinotecan—colon cancer	0.00317	0.00657	CcSEcCtD
Mupirocin—Immune system disorder—Capecitabine—colon cancer	0.00316	0.00654	CcSEcCtD
Mupirocin—Gastrointestinal pain—Vincristine—colon cancer	0.00312	0.00645	CcSEcCtD
Mupirocin—Erythema—Capecitabine—colon cancer	0.00304	0.0063	CcSEcCtD
Mupirocin—Pain—Fluorouracil—colon cancer	0.00304	0.00629	CcSEcCtD
Mupirocin—Gastrointestinal pain—Irinotecan—colon cancer	0.00303	0.00628	CcSEcCtD
Mupirocin—Abdominal pain—Vincristine—colon cancer	0.00301	0.00624	CcSEcCtD
Mupirocin—Dysgeusia—Capecitabine—colon cancer	0.00298	0.00617	CcSEcCtD
Mupirocin—Abdominal pain—Irinotecan—colon cancer	0.00293	0.00607	CcSEcCtD
Mupirocin—Urticaria—Fluorouracil—colon cancer	0.00282	0.00585	CcSEcCtD
Mupirocin—Hypersensitivity—Vincristine—colon cancer	0.00281	0.00581	CcSEcCtD
Mupirocin—Epistaxis—Methotrexate—colon cancer	0.00273	0.00566	CcSEcCtD
Mupirocin—Hypersensitivity—Irinotecan—colon cancer	0.00273	0.00566	CcSEcCtD
Mupirocin—Cough—Capecitabine—colon cancer	0.00266	0.0055	CcSEcCtD
Mupirocin—Hypersensitivity—Fluorouracil—colon cancer	0.00262	0.00542	CcSEcCtD
Mupirocin—Haemoglobin—Methotrexate—colon cancer	0.00262	0.00542	CcSEcCtD
Mupirocin—Diarrhoea—Vincristine—colon cancer	0.00261	0.0054	CcSEcCtD
Mupirocin—Haemorrhage—Methotrexate—colon cancer	0.0026	0.00539	CcSEcCtD
Mupirocin—Pharyngitis—Methotrexate—colon cancer	0.00258	0.00535	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00257	0.00533	CcSEcCtD
Mupirocin—Diarrhoea—Irinotecan—colon cancer	0.00254	0.00526	CcSEcCtD
Mupirocin—Dry mouth—Capecitabine—colon cancer	0.00253	0.00525	CcSEcCtD
Mupirocin—Dizziness—Vincristine—colon cancer	0.00252	0.00522	CcSEcCtD
Mupirocin—Pruritus—Fluorouracil—colon cancer	0.00251	0.00521	CcSEcCtD
Mupirocin—Dizziness—Irinotecan—colon cancer	0.00245	0.00508	CcSEcCtD
Mupirocin—Diarrhoea—Fluorouracil—colon cancer	0.00243	0.00503	CcSEcCtD
Mupirocin—Skin disorder—Capecitabine—colon cancer	0.00241	0.00499	CcSEcCtD
Mupirocin—Rash—Vincristine—colon cancer	0.0024	0.00497	CcSEcCtD
Mupirocin—Dermatitis—Vincristine—colon cancer	0.0024	0.00497	CcSEcCtD
Mupirocin—Headache—Vincristine—colon cancer	0.00239	0.00494	CcSEcCtD
Mupirocin—Immune system disorder—Methotrexate—colon cancer	0.00235	0.00487	CcSEcCtD
Mupirocin—Dizziness—Fluorouracil—colon cancer	0.00235	0.00487	CcSEcCtD
Mupirocin—Rash—Irinotecan—colon cancer	0.00234	0.00484	CcSEcCtD
Mupirocin—Dermatitis—Irinotecan—colon cancer	0.00234	0.00484	CcSEcCtD
Mupirocin—Headache—Irinotecan—colon cancer	0.00232	0.00481	CcSEcCtD
Mupirocin—Erythema—Methotrexate—colon cancer	0.00227	0.00469	CcSEcCtD
Mupirocin—Nausea—Vincristine—colon cancer	0.00226	0.00469	CcSEcCtD
Mupirocin—Rash—Fluorouracil—colon cancer	0.00224	0.00464	CcSEcCtD
Mupirocin—Dermatitis—Fluorouracil—colon cancer	0.00224	0.00464	CcSEcCtD
Mupirocin—Headache—Fluorouracil—colon cancer	0.00223	0.00461	CcSEcCtD
Mupirocin—Dysgeusia—Methotrexate—colon cancer	0.00222	0.00459	CcSEcCtD
Mupirocin—Nausea—Irinotecan—colon cancer	0.0022	0.00456	CcSEcCtD
Mupirocin—Pain—Capecitabine—colon cancer	0.00212	0.0044	CcSEcCtD
Mupirocin—Nausea—Fluorouracil—colon cancer	0.00211	0.00437	CcSEcCtD
Mupirocin—Gastrointestinal pain—Capecitabine—colon cancer	0.00203	0.0042	CcSEcCtD
Mupirocin—Cough—Methotrexate—colon cancer	0.00198	0.00409	CcSEcCtD
Mupirocin—Urticaria—Capecitabine—colon cancer	0.00197	0.00408	CcSEcCtD
Mupirocin—Abdominal pain—Capecitabine—colon cancer	0.00196	0.00406	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00192	0.00397	CcSEcCtD
Mupirocin—Anaphylactic shock—Methotrexate—colon cancer	0.00185	0.00383	CcSEcCtD
Mupirocin—Hypersensitivity—Capecitabine—colon cancer	0.00183	0.00379	CcSEcCtD
Mupirocin—Skin disorder—Methotrexate—colon cancer	0.0018	0.00372	CcSEcCtD
Mupirocin—Pruritus—Capecitabine—colon cancer	0.00176	0.00364	CcSEcCtD
Mupirocin—Diarrhoea—Capecitabine—colon cancer	0.0017	0.00352	CcSEcCtD
Mupirocin—Dizziness—Capecitabine—colon cancer	0.00164	0.0034	CcSEcCtD
Mupirocin—Pain—Methotrexate—colon cancer	0.00158	0.00327	CcSEcCtD
Mupirocin—Rash—Capecitabine—colon cancer	0.00157	0.00324	CcSEcCtD
Mupirocin—Dermatitis—Capecitabine—colon cancer	0.00156	0.00324	CcSEcCtD
Mupirocin—Headache—Capecitabine—colon cancer	0.00156	0.00322	CcSEcCtD
Mupirocin—Gastrointestinal pain—Methotrexate—colon cancer	0.00151	0.00313	CcSEcCtD
Mupirocin—Nausea—Capecitabine—colon cancer	0.00148	0.00305	CcSEcCtD
Mupirocin—Urticaria—Methotrexate—colon cancer	0.00147	0.00304	CcSEcCtD
Mupirocin—Abdominal pain—Methotrexate—colon cancer	0.00146	0.00303	CcSEcCtD
Mupirocin—Hypersensitivity—Methotrexate—colon cancer	0.00136	0.00282	CcSEcCtD
Mupirocin—Pruritus—Methotrexate—colon cancer	0.00131	0.00271	CcSEcCtD
Mupirocin—Diarrhoea—Methotrexate—colon cancer	0.00126	0.00262	CcSEcCtD
Mupirocin—Dizziness—Methotrexate—colon cancer	0.00122	0.00253	CcSEcCtD
Mupirocin—Rash—Methotrexate—colon cancer	0.00117	0.00241	CcSEcCtD
Mupirocin—Dermatitis—Methotrexate—colon cancer	0.00116	0.00241	CcSEcCtD
Mupirocin—Headache—Methotrexate—colon cancer	0.00116	0.0024	CcSEcCtD
Mupirocin—Nausea—Methotrexate—colon cancer	0.0011	0.00227	CcSEcCtD
